Premium Nahrungsergänzungsmittel | artgerecht

N-Acetylcarnosine: Effects, Uses & Cataracts

N-Acetylcarnosine is a naturally occurring compound that acts as a stable precursor to carnosine and is primarily used in ophthalmology for the treatment of cataracts.

Regular tips about health Regular tips about health

Things worth knowing about "N-Acetylcarnosine"

N-Acetylcarnosine is a naturally occurring compound that acts as a stable precursor to carnosine and is primarily used in ophthalmology for the treatment of cataracts.

What is N-Acetylcarnosine?

N-Acetylcarnosine (also written as N-Acetyl-Carnosine) is a naturally occurring dipeptide derivative that functions in the human body as a stable precursor to carnosine (β-alanyl-L-histidine). It is composed of the amino acids beta-alanine and histidine, with an acetyl group attached to the beta-alanine component. This chemical modification gives the compound greater stability against enzymatic degradation in the body compared to unmodified carnosine.

Mechanism of Action

N-Acetylcarnosine works primarily through two mechanisms:

Antioxidant activity: After uptake into tissue, N-Acetylcarnosine is hydrolyzed to free carnosine, which acts as a potent antioxidant by neutralizing reactive oxygen species (ROS) and thereby reducing oxidative stress.
Transcarbamoylation: N-Acetylcarnosine can act directly as a carbamoylating agent, removing oxidatively damaging carbonyl groups from proteins and lipids in a process known as transcarbamoylation.

These combined properties make N-Acetylcarnosine particularly valuable for protecting sensitive tissues such as the eye lens from oxidative damage.

Medical Applications

Ophthalmology: Cataracts

The most well-known medical application of N-Acetylcarnosine is its topical use as eye drops for the treatment and prevention of cataracts. A cataract is a clouding of the eye lens caused primarily by oxidative stress and the accumulation of oxidized proteins within the lens. N-Acetylcarnosine eye drops penetrate the cornea efficiently and accumulate in the aqueous humor and lens, where they can reduce oxidative damage.

Clinical studies, particularly by Mark Babizhayev and colleagues, demonstrated that regular application of 1% N-Acetylcarnosine eye drops over a period of 3 to 24 months can improve visual acuity and lens clarity in patients with age-related cataracts. The compound is therefore considered a potential non-surgical therapeutic option, although the evidence has not yet been conclusively confirmed by large randomized controlled trials.

Further Potential Applications

Neurodegenerative diseases: Due to the antioxidant and anti-glycation properties of carnosine, N-Acetylcarnosine is being investigated in research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Anti-aging: As a dietary supplement, N-Acetylcarnosine is marketed to promote general antioxidant protection and slow aging processes.
Sports medicine: Similar to carnosine, N-Acetylcarnosine is discussed in the context of muscle recovery and athletic performance.

Dosage and Usage Notes

In clinical studies for the treatment of cataracts, N-Acetylcarnosine was typically administered as a 1% aqueous solution (eye drops). The common dosage was 1–2 drops per eye, twice daily. As an oral dietary supplement, dosages of 100 to 500 mg per day are discussed, though standardized clinical recommendations are still lacking. Use should always be in consultation with a physician or pharmacist.

Safety and Side Effects

N-Acetylcarnosine is generally considered well tolerated. Studies on topical use as eye drops have reported few side effects. Possible mild side effects may include:

Temporary burning or tingling in the eye after application
Mild temporary blurring of vision

No serious side effects are known for oral intake as a supplement. Pregnant or breastfeeding individuals and persons with pre-existing eye conditions should seek medical advice before use.

Distinction from Carnosine and Related Compounds

While carnosine is rapidly degraded in the body by the enzyme carnosinase, N-Acetylcarnosine is more resistant to this breakdown. This significantly increases the bioavailability and duration of action of the compound in tissue. In contrast to pure L-carnosine or beta-alanine as supplements, N-Acetylcarnosine therefore provides a more efficient delivery of active carnosine equivalents, especially to the eye lens.

References

Babizhayev, M.A. et al. (2002): Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs in R&D, 3(2), 87–103.
Hipkiss, A.R. (2009): Carnosine and its possible roles in nutrition and health. Advances in Food and Nutrition Research, 57, 87–154.
Boldyrev, A.A., Aldini, G., Derave, W. (2013): Physiology and pathophysiology of carnosine. Physiological Reviews, 93(4), 1803–1845.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.